Navigation Links
Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles
Date:8/27/2012

rminated Trial Analysis 495 Endpoints - Clinical Trials in Chronic Obstructive Pulmonary Disorder - Marketed and Pipeline Products Assessment 765.1 Introduction 765.2 Primary Endpoints Used in COPD Clinical Trials 805.2.1 Pulmonary Function Tests 805.2.2 Baseline Dyspnea Index and Borg-Dyspnea Score 805.2.3 Rate of Exacerbations 805.2.4 Induced Sputum Analysis 805.2.5 Biomarkers of COPD 805.3 Secondary Endpoints Used in COPD Clinical Trials 805.3.1 Exercise Endurance Time 805.3.2 Serum Hematology 805.3.3 Six Minute Walk Distance 805.3.4 Time to First Exacerbation 815.4 COPD Therapeutics – Major Marketed Drugs 815.4.1 Spiriva HandiHaler (Tiotropium Bromide Inhalation Powder) 815.4.2 Brovana (Arformoterol) 825.4.3 Foradil Aerolizer (Formoterol Fumarate Inhalation Powder) 835.4.4 Symbicort (Budesonide/Formoterol Fumarate Dihydrate) 845.4.5 Advair Diskus (Fluticasone Propionate and Salmeterol Inhalation Powder) 855.4.6 Daxas (roflumilast) 875.5 COPD Therapeutics – Promising Drugs Under Clinical Development 885.5.1 Aclidinium Bromide 885.5.2 NVA237 (Glycopyrronium Bromide) 895.5.3 Dulera 895.6 Phase III Clinical Trial Analysis 905.6.1 Completed Trial Analysis 905.6.2 Active Trials Analysis 945.6.3 Terminated Trial Analysis 985.7 Phase II Clinical Trial Analysis 1005.7.1 Completed Trial Analysis 1005.7.2 Active Trial Analysis 1045.7.3 Terminated Trial Analysis 1076 Endpoints - Clinical Trials in Cystic Fibrosis - Marketed and Pipeline Products Assessment 1256.1 Introduction 1256.2 Primary Endpoints Used in Cystic Fibrosis Clinical Trials 1296.2.1 Coefficient of Fat Absorption 1296.2.2 Lung Microbiology 1296.2.3 Biomarkers 1296.3 Secondary Endpoints Used in Cystic Fibrosis Clinical Trials 1296.3.1 Nasal Potential Difference 1296.3.2 Sweat Chloride Concentration 1296.4 Cystic Fibrosis Therapeutics – Major Marketed Drugs 1296.4.1 Tobi (Tobramycin Inhalation Solution) 1296.4.2 Pulmozyme (Dornase Alfa) 1306.4.3 Cayston (aztreonam for Inhalation Solution) 1316
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
2. As Tuberculosis Grows More Difficult to Control, Vaccine Candidate to Prevent Disease Enters Clinical Testing
3. Millennium Laboratories Announces Landmark Pharmacogenetics Clinical Outcomes Study
4. VolitionRX to Begin Prospective Clinical Trial in Colon Cancer
5. Indegene Introduces TrialPedia 2.0 with Advantage Insights, Making It the Most Comprehensive Clinical Trial Analytics and Decision Support Platform for the Pharma Industry
6. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
7. AbGenomics International Obtains FDA Agreement on Its Phase 2 Clinical Trial Plans
8. Nectid Announces Initiation Of Clinical Development Of Autism And Pain Drugs
9. Meritage Pharma Initiates Clinical Trial of Oral Budesonide Suspension for Adolescent and Adult Patients with Eosinophilic Esophagitis
10. MultiCell Technologies Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in vitro Models
11. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... , April 27, 2015   AMC Health , ... showcase advances in monitored care that are transforming chronic ... ATA 2015 Conference, May 2-5 at the ... Health will share information about how their innovative ... help transform and personalize healthcare delivery at Booth #2116 ...
(Date:4/27/2015)... NEW YORK , April 27, 2015 ... claims against the board of directors of Aerie Pharmaceuticals, ... concerning whether the board has breached its fiduciary duties ... Company issued a press release announcing results from its ... things, the press release disclosed that in the trial, ...
(Date:4/27/2015)... 2015  USL di Reggio Emilia, the Regional Health ... has implemented Zebra Technologies Corporation (NASDAQ: ... Wireless Network Solution (WNS) provided by Zebra has ... in real time via mobile computers, contributing to improved ... also provides employee and guest Wi-Fi access and enables ...
Breaking Medicine Technology:AMC Health to Showcase Advances in Monitored Care at ATA 2015 2AMC Health to Showcase Advances in Monitored Care at ATA 2015 3AMC Health to Showcase Advances in Monitored Care at ATA 2015 4Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc. 2Zebra Technologies' Wireless Solutions Help Reggio Emilia Hospital Staff Improve Patient Care and Reduce Costs 2Zebra Technologies' Wireless Solutions Help Reggio Emilia Hospital Staff Improve Patient Care and Reduce Costs 3Zebra Technologies' Wireless Solutions Help Reggio Emilia Hospital Staff Improve Patient Care and Reduce Costs 4Zebra Technologies' Wireless Solutions Help Reggio Emilia Hospital Staff Improve Patient Care and Reduce Costs 5
... NEW YORK, Nov. 9 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. ... pharmaceutical,company dedicated to improving health through the development, manufacture ... the counter ("OTC"),products, today announced that it plans to ... 2009, after the market closes. , ...
... 9, 2009 Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) today ... , Arena reported a lower net loss allocable to common stockholders ... per share, compared to a net loss allocable to common stockholders ... per share, and a net loss allocable to common stockholders in ...
Cached Medicine Technology:Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9
(Date:4/27/2015)... New York, NY (PRWEB) April 27, 2015 ... Jimmy Buffett tickets at the Alpine Valley Music ... in the Elkhart, Wisconsin and Albuquerque, New Mexico area ... in their neck of the woods. Buffett will ... News in Wisconsin. His tour stops during the ...
(Date:4/27/2015)... 2015 Telematics Berlin is Europe’s biggest ... associations, CE players and the government to discuss the ... the car. This year’s panel on connected car security ... European Commission, is an opportunity to hear and contribute ... European Automotive Security Standard for years to come. ...
(Date:4/27/2015)... The global coagulation analyzers market is ... developed countries; however, it is expected to witness ... India and Brazil in the next five years. ... by factors such as increasing adoption of automated ... hemostasis analyzers, developments in high-sensitivity point-of-care coagulation analyzers ...
(Date:4/27/2015)... April 27, 2015 Attorney Dan Newlin, of ... serving and protecting his clients, took that commitment to a ... dialing code which makes it easier for existing and potential ... on building his brand and added value to the firm’s ... Chicago area where Newlin has law offices. , “I knew ...
(Date:4/27/2015)... Volpara Solutions today announced the release ... of Breast Imaging’s SBI/ACR Breast Imaging Symposium in ... VolparaDensity, the first breast density assessment tool ... datasets from multiple manufacturers, is already in use ... , The latest version of VolparaDensity ...
Breaking Medicine News(10 mins):Health News:Cheap Jimmy Buffett Tickets at Alpine Valley Music Theatre in Elkhorn, WI and at Isleta Amphitheater in Albuquerque, NM Now on Sale at TicketDown.com 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 3Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 3Health News:Dan Newlin Hashtags It With #Dan 2Health News:Volpara Solutions Releases VolparaDensity 3.1 for Use with Tomosynthesis Systems from Multiple Manufacturers at SBI 2Health News:Volpara Solutions Releases VolparaDensity 3.1 for Use with Tomosynthesis Systems from Multiple Manufacturers at SBI 3
... at the Center for Translational Social Neuroscience (CTSN) at ... new model to screen the effectiveness of drugs to ... a drug Emory researchers have shown enhances behavioral therapy ... voles. Giving female voles D-cycloserine, which is thought to ...
... DETROIT A new Henry Ford Hospital study takes a ... most serious side-effects of ACE inhibitor use facial, tongue ... invasive course of treatment. Using a treatment ... and promptly treated to reduce swelling, resulting in no tracheotomies ...
... radiation oncologist practiced were two factors that strongly influenced the ... according to an article published April 29 online in ... of IMRT and the cost of radiation therapy increased sharply ... radiation delivery technique that modulates the radiation beams to conform ...
... HealthDay Reporter , WEDNESDAY, April 27 (HealthDay News) -- The ... a new claim to fame: leprosy. A new ... and have somehow passed the disease to several dozen humans ... long-suspected link between leprosy in humans and armadillos," said the ...
... April 27 (HealthDay News) -- If you suffer a heart attack ... having one at any other time of day, a Spanish research ... 6 a.m. and noon, it is likely to damage about 20 ... afternoon or evening, the researchers added. "It is well-known for ...
... under adult supervision does not appear to teach responsible drinking ... may actually lead to more drinking and alcohol-related consequences, according ... the Journal of Studies on Alcohol and Drugs . ... according to the study,s lead researcher, Barbara J. McMorris, Ph.D., ...
Cached Medicine News:Health News:Social bonding in prairie voles helps guide search for autism treatments 2Health News:Social bonding in prairie voles helps guide search for autism treatments 3Health News:Study targets treatment for serious ACE inhibitor side effect 2Health News:Use of costly breast cancer therapy strongly influenced by reimbursement policy 2Health News:Armadillos Give Leprosy to Humans in Southern U.S.: Study 2Health News:Armadillos Give Leprosy to Humans in Southern U.S.: Study 3Health News:Morning Heart Attacks Cause More Damage, Study Finds 2Health News:Morning Heart Attacks Cause More Damage, Study Finds 3Health News:Adult-supervised drinking in young teens may lead to more alcohol use, consequences 2
... offers a range of standard, enhanced ... delivers therapy to meet the needs ... in commercial and clinical effectiveness and ... the SleepStyle 200 series is the ...
... The ResMed S6 Lightweight II CPAP ... microprocessor-controlled motor that maintains consistent pressure. ... and adjusting the settings easy, and ... and make adjustments is simple. This ...
The S8 Escape is the economy model of ResMeds S8 series. The S8 Escape is ideal for patients who want the convenience and portability of the S8 models but do not require the added comfort features of...
The S7 Elite is the premium device in ResMeds award-winning S7 series. All S7 devices include an option of integrated humidification....
Medicine Products: